APA

Xue C., Wei W., Sun P., Zheng W., Diao X., Xu F., Huang J., An X., Xia W., Hong R., Jiang K., Huang R., Yuan Z., Wang S., Li A., Zou R. & Shi Y. (20190613). Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer. : Breast cancer research and treatment.

Chicago

Xue Cong, Wei Wenwen, Sun Peng, Zheng Wei, Diao Xiaoju, Xu Fei, Huang Jiajia, An Xin, Xia Wen, Hong Ruoxi, Jiang Kuikui, Huang Riqing, Yuan Zhongyu, Wang Shusen, Li Anhua, Zou Ruhai and Shi Yanxia. 20190613. Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer. : Breast cancer research and treatment.

Harvard

Xue C., Wei W., Sun P., Zheng W., Diao X., Xu F., Huang J., An X., Xia W., Hong R., Jiang K., Huang R., Yuan Z., Wang S., Li A., Zou R. and Shi Y. (20190613). Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer. : Breast cancer research and treatment.

MLA

Xue Cong, Wei Wenwen, Sun Peng, Zheng Wei, Diao Xiaoju, Xu Fei, Huang Jiajia, An Xin, Xia Wen, Hong Ruoxi, Jiang Kuikui, Huang Riqing, Yuan Zhongyu, Wang Shusen, Li Anhua, Zou Ruhai and Shi Yanxia. Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer. : Breast cancer research and treatment. 20190613.